Claudia Cardone
@clacardone
MD, PhD. GI Medical Oncologist @istitutotumori. #MCCR17. @myesmo. Neapolitan. European. #endowarrior 🎗️. Tweets are my own.
ID:871650506900463616
https://www.linkedin.com/in/claudia-cardone-325b50182 05-06-2017 08:50:50
1,1K Tweets
1,3K Followers
1,2K Following
Follow People
👉The last webinar in the #PrecisionOncology series is now available to the entire oncology community.
Access with your ESMO account: 🔗ow.ly/QbL750Rj8oz
Claudia Cardone Vivek Subbiah, MD Sewanti Limaye 🇮🇳🇺🇸 Ben Westphalen George Pentheroudakis
🚨Curious about #Tumour #agnostic treatments? Don't miss out! Join us tomorrow for an illuminating #PrecisionOncology webinar featuring international experts.
👉There's still time to register. See you there! 🌟 ESMO - Eur. Oncology Annals of Oncology
Register now with your ESMO account:…
The #PrecisionOncology webinar presents ESMO’s new proposal for a classification of tissue-agnostic therapeutics. Register now for free and take part in this live interaction with international experts.
È con grande orgoglio e soddisfazione che vi comunichiamo l'approvazione al Senato della Repubblica della Legge per il #dirittoallobliooncologico .
È stato premiato l’impegno di tutti quelli che hanno creduto in questa legge di civiltà che abbiamo affrontato con Fondazione Aiom.
The first piece of knowledge from PARERE trial by GONO Foundation
✅ > 200 pts candidate to antiEGFR rechallenge screened with #liquidbiopsy 🩸
⛔️38% RAS or BRAF mutations in ctDNA
🔢 30% RAS/BRAF wt cases with at least one potential mechanism of resistance
Paolo Ciracì
👏🏼Kudos to Daniele Rossini Chiara Cremolini and team for their latest work, part of our research topic exploring🩸 #liquidbiopsy in #CRC
🗣️ frontiersin.org/research-topic…
Frontiers - Oncology Alfonso De Stefano Sergio Facchini
👇🏼
preliminary data from the ph 2 #PARERE trial frontiersin.org/articles/10.33…
👏🏼Congrats to Pashtoon Kasi MD, MS and team for their latest work, part of our research topic exploring🩸 liquid biopsy in CRC
🗣️ frontiersin.org/research-topic…
Frontiers - Oncology Alfonso De Stefano Sergio Facchini
👇🏼
What just happened? 5 new 💊/indications ✅ by FDA Oncology in the last 10 days. As #CommunityOncologists , we need to know them all:
1. #Fruquintinib in refractory mCRC, mPFS 3.7mos vs 1.8mos
2. #Pembrolizumab (+Chemo) in 1L mGEJ/Gastric Ca, mOS 12.9mos Vs 11.5mos…
Patient preference for place of death is unique to their individual circumstances & belief systems 👉faith, symptom burden, social support, socioeconomic status, & geography may affect the delivery of quality #endoflife care. #OvarianCancer #gyncsm #hpm
📍journals.lww.com/greenjournal/f…
#AIOM23 Massimo Di Maio, next president elect
“The person I would like to be in 10 years”, as Matteo Lambertini, MD PhD said this morning👏🏼
AIOM
#AIOM23 AIOM
Big thank to #aiomgiovani for the kind invitation
Amazing track dedicated to #YoungOncologists
Amazing talks by Massimo Di Maio Pasquale Lombardi arsela prelaj
What a big honour for Claudia Cardone & I to be here at #SOF23 !
Thank you 🙏 SOF Narodowy Instytut Onkologii, Warszawa for the kind invitation & excellent organisation. So impressed! It’s been inspiring for me to meet & interact with so many enthusiastic budding doctors - hopefully oncologists. Keep believing!
#SOF23 Narodowy Instytut Onkologii, Warszawa
Claudia Cardone 🇮🇹 inspiring our new generation of medical students (and hopefully budding 🇵🇱 oncologists)!
Mentorship can be key 🔑 to a fruitful & satisfying career. Mentors come in many kinds, and numerous platforms - it’s up to you to take the first step 🙌.